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Abstract
Background: The NF-kB activating kinases, IKKa and IKKb, are key regulators of inflammation and immunity in response to
infection by a variety of pathogens. Both IKKa and IKKb have been reported to modulate either pro- or anti- inflammatory
programs, which may be specific to the infectious organism or the target tissue. Here, we analyzed the requirements for the
IKKs in myeloid cells in vivo in response to Francisella tularensis Live Vaccine Strain (Ft. LVS) infection.
Methods and Principal Findings: In contrast to prior reports in which conditional deletion of IKKb in the myeloid lineage
promoted survival and conferred resistance to an in vivo group B streptococcus infection, we show that mice with
a comparable conditional deletion (IKKb cKO) succumb more rapidly to lethal Ft. LVS infection and are unable to control
bacterial growth at sublethal doses. Flow cytometry analysis of hepatic non-parenchymal cells from infected mice reveals
that IKKb inhibits M1 classical macrophage activation two days post infection, which has the collateral effect of suppressing
IFN-c+ CD8+ T cells. Despite this early enhanced inflammation, IKKb cKO mice are unable to control infection; and this
coincides with a shift toward M2a polarized macrophages. In comparison, we find that myeloid IKKa is dispensable for
survival and bacterial control. However, both IKKa and IKKb have effects on hepatic granuloma development. IKKa cKO mice
develop fewer, but well-contained granulomas that accumulate excess necrotic cells after 9 days of infection; while IKKb
cKO mice develop numerous micro-granulomas that are less well contained.
Conclusions: Taken together our findings reveal that unlike IKKa, IKKb has multiple, contrasting roles in this bacterial
infection model by acting in an anti-inflammatory capacity at early times towards sublethal Ft. LVS infection; but in spite of
this, macrophage IKKb is also a critical effector for host survival and efficient pathogen clearance.
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the role of IKKa in the canonical signalosome is less clear. In
addition, IKKa and IKKb have also been shown to possess
a variety of NF-kB-independent functions by regulating effectors
of cell cycling, apoptosis, specific cellular differentiation pathways,
chromatin activity and inflammatory responses {reviewed in.
[5,6,7,8]).
In addition to the well-established roles the IKKs have on the
induction of inflammation and adaptive immune responses,
myeloid IKKa and IKKb also limit inflammation in response to
the extracellular bacterium Group B Streptococcus (GBS) or by E.
coli LPS- (lipopolysaccharide) induced septic shock [9,10,11,12].
This unexpected behavior of the IKKs in myeloid cells led us to
further investigate their anti-inflammatory properties in the
context of the intracellular bacterium Francisella tularensis (Ft.).

Introduction
NF-kB is an important signaling pathway for the induction and
regulation of innate and adaptive immune responses toward
bacterial infection. Microbial components and pro-inflammatory
stress-like signals universally impact the activation of NF-kB
transcription factors via the inhibitor of NF-kB kinase (IKK)
signalosome complex. The signalosome contains two catalytic
kinases, IKKa and IKKb, and a third docking/regulatory subunit,
IKKc/NEMO [1]. The catalytic IKKs mediate the phosphorylation and subsequent degradation of the IkB family of cytoplasmic inhibitory proteins. IkB degradation liberates NF-kB
transcription factors, resulting in nuclear translocation and target
gene activation (for reviews see [2,3,4]). Canonical NF-kB
activation requires IKKb and IKKc for IkB degradation, while
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We found that myeloid IKKb is required for survival during
septic challenge, while IKKa cKO mice displayed mortality rates
comparable to control mice. In a sublethal model of infection, flow
cytometry anaylsis of hepatic non-parenchymal cells showed that
loss of myeloid IKKb, but not IKKa, results in polarization
toward M1 macrophages in the liver early in the course of
infection. Interestingly we found these effects are transient, as by
mid-infection, macrophages polarize towards the M2a lineage.
Loss of myeloid IKKb also induces protracted elevations in IFN-c
expressing CD8+ T cells, which persist throughout the course of
infection. Despite these changes, IKKb cKO mice are defective in
control of bacterial growth. Finally, histological analysis shows that
infection results in abnormal granulomatous liver responses in
both strains of IKK cKO mice.

Francisella tularensis is a highly infectious, Gram-negative, intracellular bacterium and is the causative agent of tularemia. Due
to the high virulence of the human pathogenic strain ShuS4, the
attenuated Live Vaccine Strain (Ft. LVS) is commonly used in
mouse models of infection due to its ability to approximate human
disease [13,14]. Ft. infects several cell types [15,16,17,18,19,20],
but macrophages are considered the primary target of early
infection [19,21,22]. Bacteria disseminate to colonize the lungs,
liver and spleen presumably through the hematogenous route
[13,23]. Examination of Ft. LVS or ShuS4 infected organs
indicates that lung, liver and spleen each contribute distinct
immune reactions [15,24,25,26]. Within 72 hours of intradermal
(i.d.) or intraperitoneal (i.p.) inoculation of Ft. LVS, a pro
inflammatory gene expression profile is evident in liver and to
a lesser extent in spleen, while lungs respond in an anti
inflammatory manner [24].
The virulence of Francisella has been attributed to its ability to
down-modulate and/or evade host defenses. For example, outside
the cell, Francisella are opsonized with complement proteins but are
able to resist killing by complement-mediated lysis [27,28,29].
Opsonized bacteria are taken up readily by phagocytic cells, but
avoid degradation by preventing fusion of host phagosomes to
lysosomes and subsequently escape to the cytosol where they
replicate [30,31,32,33]. Although Ft. is a Gram-negative bacterium, it has evolved an unusual LPS structure, which only minimally
activates the pattern recognition receptor TLR4 (Toll-like Receptor-4) [34,35,36], and instead, innate immune recognition of
Ft. LVS is mediated through TLR2 (Toll-like receptor-2)
[37,38,39,40].
Francisella also interferes with anti-microbial defenses and
inflammatory signaling pathways in several cell types, including
macrophages and neutrophils. For example, Ft. LVS can prevent
anti-microbial ROS (reactive oxygen species) production and
NADPH oxidase assembly in human neutrophils [18]. Ft. LVS
actively down-modulates TNF-a and IL-1 in the J774A murine
macrophage cell line; this coincides with the inhibition of IkBa
degradation and cross-tolerization to E. coli LPS (a TLR4 agonist)
resulting in interference of NF-kB signaling [41,42].
There is also evidence that Ft. LVS affects macrophage
polarization [43]. As early as 24 hours post infection, infected
peritoneal elicited macrophages show properties of anti-inflammatory, alternatively-activated/M2 polarization resulting in increased expression of the M2 markers: mannose receptor (CD206),
Fizz-1, Arg-1 and Ym1 [43]. Similar to the T cell polarization
paradigm, macrophage polarization also depends on cytokine cues
induced by the local environment (reviewed in [44,45]). In
agreement with this, Francisella interferes with IFN-c signaling,
a key cytokine involved in macrophage polarization and bacterial
control. Ft. LVS and its closely related subspecies Ft. novicida
modulate IFN-c signaling by suppressing tyrosine phosphorylation
of the STAT1 transcription factor (Signal Transducer and
Activator of Transcription 1) in human and murine mononuclear
cells and this correlates with up-regulation of the STAT1 inhibitor
SOCS3 (suppressor of cytokine signaling) [46].
Since infection with Ft. suppresses key inflammatory regulators,
we hypothesized that the anti-inflammatory properties of myeloid
IKK may compound and/or contribute to the progression of
tularemia in vivo. To investigate this, we used myeloid-specific
conditional knockout mice (IKK cKO) [47] to assess the roles of
the IKKs in an intradermal (i.d.) model of Ft. LVS infection. We
chose the liver as the model organ for our study because during
tularemic infection, it supports pro-inflammatory changes [24], is
colonized early in infection and has an abundant source of
macrophages [48].
PLOS ONE | www.plosone.org

Methods
Animals
Myeloid specific ikk deletions were generated by crossing
IKKa or IKKb floxed mice with the LysM Cre expressing
mouse strain [49] to generate IKKa flox/flox-LysM Cre or IKKb
flox/flox
-LysM Cre strains, all of which were maintained on
a C57BL/6 genetic background, as previously described [47].
To simplify nomenclature used throughout this text, mice are
herein referred to as IKKf/f to represent control IKK floxed
strains without myeloid deletion and IKKa cKO or IKKb cKO
to represent corresponding myeloid ikk conditional deletions.
Mice were housed in a facility equipped with a 12:12 hour
light:dark cycle in ventilated cages; and were fed a normal chow
diet and autoclaved water ad libitum.

Ethics Statement
All procedures were performed in strict accordance with State
University of New York at Stony Brook IACUC approved
protocol (Permit Number 0163).

Bacteria
Ft. LVS (ATCC 29684, American Type Culture Collection,
Manassas, VA) were a kind gift from the laboratory of Dr. Martha
Furie, and were grown according to published protocols [50].
Briefly, frozen stocks were streaked on chocolate II agar
supplemented with hemoglobin and IsoVitaleX (BD Biosciences,
San Jose, CA) and grown at 37uC for 3 days. Single colonies were
inoculated into pre-warmed (37uC, 5% CO2) Mueller Hinton-II
broth and incubated at 37uC with shaking for 16–18 h. Bacteria
were used at OD600 between 0.2–0.4.

Infection Model
Bacteria were serially diluted to the indicated doses in sterile
PBS in a final volume of 100 ml. Eight- to twenty-week old female
mice were shaved and injected intradermally (i.d.) at the base of
the tail. Mice were monitored for signs of illness (hunched posture,
ruffled fur, loss of appetite, etc.). At lethal doses, these symptoms
sometimes did not appear until hours before succumbing to
infection. In addition, occasionally mice that appeared ill had
spontaneously recovered. Sublethal infection did not induce
symptoms of illness. Doses, listed as colony forming units (CFU),
were confirmed by a retroplate colony count assay as described
below.

Survival Analysis
The 50% Lethal Dose (LD50), was determined using the
IKKf/f parental strain. Mice were infected i.d. with 106, 107 or
108 CFU of Ft. LVS and monitored daily for survival.
2
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inhibited using Peroxidazed-1 blocking reagent (Biocare Medical)
for 5 minutes prior to blocking in goat serum. CC-3 primary
antibody (Cell Signaling Technology, Danvers, MA) was diluted
1:50 and applied as above. A secondary goat anti-rabbit antibody
(1:500 dilution; supplied with Vectastain, ABC kit, Vector
Laboratories, Burlington, CA) was applied for 30 minutes. Slides
were rinsed in Tris buffer and ABC reagent from the same kit
was added for 30 minutes. ImmPACTTM DAB solution (Vector
Labs) was applied for 6 minutes, rinsed and counterstained as
above. Staining was absent in control slides where primary
antibody was omitted. Occasional weak background was noted in
uninfected controls. Images of immunostained slides were
captured using a 206 objective on an Aperio ScanScope CS
slide scanner (Aperio,Vista, CA ) to create whole-slide digital
images. Images were subsequently analyzed using Aperio
ImageScope v11.12.2.760 Positive-Pixel Count Algorithm v9
(Aperio) for systematic identification of Ft. antigen, iNOS or
cleaved caspase-3 positivity. The software samples the image and
reports a staining intensity (a value proportional to the amount of
transmitted light) and generates a pseudo-colored markup image
to verify staining intensities. Staining intensities are thus reported
as negative (255, blue), weak positive (220, yellow), positive (175,
orange) and strong positive (100, brown). Using these parameters,
we defined weak positive (yellow) as non-specific/background
staining, while positive and strong positive values (orange+red/
brown) were considered to be specific staining. The algorithm
was applied to both positive and negative control tissues to
ensure validity of the settings.
Positive granulomas were counted by examination of 10 fields/
liver under 2006 magnification. Poisson distribution was assumed
and fitted to Poisson regression by taking the square root of count
data and mean comparisons were made with one-way ANOVA
and Tukey’s post-test. Data are represented as percent positive
granulomas.

For comparison of survival between all strains, mice (10–15 per
group) were injected with an LD50 dose 108 CFU i.d. and
monitored twice daily over a period of 14 days. Kaplan-Meier
survival curves were generated and relative mortalities in response
to lethal infection were compared by Mantel-Cox log-rank test.

Organ Burden Determination and Retroplate Colony
Counts
Organ burden was determined using limiting-dilution culture.
Briefly, sections of the median lobe (,0.1–0.2 g) of infected livers
were aseptically removed and placed in a pre-weighed sterile tube
containing 1 ml of sterile PBS. The remaining liver and section
were weighed. The section was homogenized in a stomacher bag
(Fisher Scientific, Pittsburgh, PA) and serially diluted. Neat
homogenates and serial dilutions were plated and incubated for
3 days at 37uC. The resulting colonies were counted and
represented as a concentration per gram of liver. This concentration was then multiplied by the weight of the total liver and
corresponding dilution factor to derive the total organ burden.
Retroplate colony counts were performed in a similar manner.
First, serial dilutions on the inoculation dose were made. Dilutions
were then plated and incubated as above. The resulting colonies
were counted, multiplied to respective dilution factors and
represented as CFU/ml. The limit of detection for these assays
was 200 CFU.

Histology
Organs were fixed in 10% neutral buffered formalin (Sigma
Diagnotics, St. Louis, MO) and embedded in paraffin, sectioned at
5 mm rehydrated to water through graded alcohols. Tissues were
stained with hematoxylin and eosin (H & E), dehydrated in graded
alcohols, cleared with xylene and mounted with Acrymount (EMS,
Hatfield, PA). An experienced pathologist performed a blinded
analysis on H & E sections to identify any abnormalities in lung,
liver and spleen. Images were captured on an Olympus BX41 light
microscope (Olympus, Tokyo, Japan).
Granuloma counts from 8 mice/group were quantified by
examination of 10 fields/liver under 2006 magnification. Poisson
distribution was assumed and fitted to Poisson regression by taking
the square root of count data and mean comparisons were made
with one-way ANOVA and Tukey’s post-test. Data was then backtransformed into original units of granulomas/2006 field
(0.150 mm2).

Non-parenchymal Cell (NPC) Isolation
NPC’s were isolated by the methods of Rasmussen et al [51].
Briefly, mice were injected with 106 CFU of Ft. LVS and
euthanized at the indicated time points. On the day of harvest,
livers were perfused with 1 mM Citrate (Sigma, St. Louis, MO) in
Hanks Buffered Saline Solution (HBSS, Gibco/Invitrogen Carlsbad, CA). Livers were minced to 1 mm pieces and placed in digest
buffer containing 0.05% Collagenase II, 0.002% DNAse1 and 1%
BSA (all from Sigma-Aldrich, St. Louis, MO) in HBSS, rotating at
75 RPM, 37uC for 45 minutes. Digests were triturated 10X and
filtered through a 70 mm cell strainer (BD Falcon, San Jose, CA).
Cells were pelleted and resuspended in ACK hypotonic buffer
(0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA) for 5
minutes to lyse RBCs. Cells were washed in PBS and NPCs were
isolated by flotation method using Optiprep density gradient
(AxisShield, Oslo, Norway), according to manufacturer protocol
C-24. Upper and lower isolates were collected and the NPC
fraction was confirmed by flow cytometry. The upper isolate was
.97% CD45+ (eBioscieinces, San Diego, CA).

Immunohistochemistry
Tissues were fixed in neutral-buffered formalin for 48 hrs,
embedded in paraffin and sectioned at 5 mm. Deparaffinization,
rehydration and antigen retrieval was performed by incubating
slides in TrilogyTM solution (Cell Marque, Rocklin, CA) for 1 hr
at 90uC. Slides were rinsed in TBST (Tris Buffered SalineTween; Thermo-Scientific, Freemont, CA), blocked in goat
serum for 30 minutes at RT, and rinsed again in Tris buffer.
Slides were incubated with polyclonal anti-Ft. LVS rabbit serum
or anti-iNOS (Abcam, Cambridge, MA) primary antibody
(diluted 1:50 in Tris buffer) for 16 hours at 4uC. Slides were
rinsed and then incubated with AP-conjugated goat anti-rabbit
secondary antibody (diluted 1:100; Invitrogen, Carlsbad, CA)
and developed using Vulcan Fast Red Chromagen (Biocare
Medical, Concord, CA) for 10 minutes. To counterstain, slides
were rinsed in H2O and dipped twice in Mayer’s Hematoxylin
(Cancer Diagnostics, Morrisville, NC). Slides prepared for the
detection of cleaved caspase-3 (CC-3) were processed in similar
manner with a few modifications. Endogenous peroxidase was
PLOS ONE | www.plosone.org

Flow Cytometry
NPCs isolated from infected livers were stained with antibodies
for surface and/or intracellular markers for immunophenotyping
and cytokine positivity according to manufacturer suggested
protocols. Briefly, harvested cells were immediately incubated in
growth media (RPMI 1640, 5% heat inactivated FBS (Invitrogen/
Life Technologies, Carlsbad, CA) without antibiotics) containing
1 mg/ml GolgiPlug (BD Biosciences, San Jose, CA) for 6 hours to
prevent cytokine release; no exogenous stimuli were added during
3
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the incubation period. GolgiPlug was added to all subsequent flow
cytometry buffers until the fixation step. Cells were washed 1X in
PBS and 1X in FACS Stain Buffer (FSB: 1% heat inactivated FBS,
0.09% w/v NaN3 in PBS). Fcc receptors were blocked with
CD16/32 antibody (eBiosciences, San Diego, CA). Surface
epitopes were stained with antibody for 30 min., washed 2 times
with FSB. Cells were fixed and permeabilized using BD Cytofix/
Cytoperm buffer kit (BD Biosciences, San Jose, CA) for 20 min.
Intracellular antibodies were added to cells and incubated for
30 min. Unlabeled antibodies required secondary labeling was
carried out in a third staining step as above. All labeling and
permeabilization steps took place in the dark with rotation. The
following antibodies were used in this study: Arg-1 (Everest
Biotech, Oxfordshire, UK), PE-CD3a (B111922, BioLegend, San
Diego, CA), FITC-CD3e (145-2C11, eBiosciences, San Diego,
CA), FITC-CD4 (RM4-5, BioLegend), FITC-CD8a (53-6.7,
BioLegend), PE-CD11b (M1-70, BioLegend), PerCP-Cy5.5CD11b (M1-70, BD Biosciences, San Jose, CA), FITC-CD45
(30.F11, BioLegend), APC-F4/80 (BM8, eBiosciences), FITC-F4/
80 (BM8, eBiosciences), Ft. LVS (Rabbit polyclonal, a generous
gift of Dr. Jorge Benach), APC-IFN-c (XMG1.2, BD Biosciences),
PE-IL-10 (JES5-16E3, BD Biosciences), APC-IL-12p40/70
(C15.6, BD Biosciences), FITC-pan-Neutrophils/Ly-6B.2 (7/4,
AbD Serotec, Raleigh, NC), PerCP-Cy5.5-NK1.1 (PK136, BD
Biosciences), RELMa/FIZZ1 (Rabbit Polyclonal, Abcam, Cambridge, MA), PE-Donkey anti rabbit IgG (Abcam), PE-Donkey
anti goat IgG (Abcam). Acquisition was performed on FacsCalibur
flow cytometer (BD Biosciences, San Jose, CA) and data was
analyzed using FlowJo V9.0.1, (TreeStar, Ashland, OR). Cell
counts are normalized as counts per gram of liver.

Figure 1. Myeloid IKKb is essential for host resistance to
a lethal, i.d. Ft. LVS infection. IKKf/f, IKKa cKO and IKKb cKO mice
were injected i.d. with the LD50 dose of 108 CFU of Ft. LVS and
monitored for survival by the Kaplan-Meier method (n = 10–15 mice per
group; Log-rank P value = 0.0014).
doi:10.1371/journal.pone.0054124.g001

Both IKKa and IKKb in Myeloid Cells Contribute to
Granulomatous Response in the Liver during Sublethal
Ft. LVS Infection
Next we asked how conditional loss of either IKK in myeloid
cells affects disease progression using a sublethal model of
infection. In order to determine the sublethal dose, we tested
mice at lower doses of inoculum (Fig. S1 B–C). IKKf/f and IKKa
cKO mice had an 80% survival rate at 107 CFU of Ft. LVS, in
contrast IKKb cKO mice showed increased sensitivity to infection
resulting in a 60% survival rate at this same dose. All three strains
of mice survived i.d. infection of 106 CFU of Ft. LVS for a period
of 90 days; and thus we used this dose for all sublethal
experiments.
Infection with Ft. LVS results in dissemination to lung, liver and
spleen, and results in inflammatory infiltration and/or development of granuloma-like foci in target organs. We examined these
tissues by hematoxylin and eosin (H & E) staining in a time course
experiment to assess histopathological changes.
Lung histology was normal in all three strains of mice prior to
infection (data not shown). At two days post-infection, mild lung
reactions were observed (Fig. 2A–C and Fig. S2). Peribronchial
inflammatory infiltrates were sometimes present and consisted
largely mononuclear cells and a few neutrophils (Fig. 2A and C,
insets). Areas of peribronchial infiltrate were more numerous in
IKKb cKO mice and these infiltrates also contained lymphocytes
(Fig. 2C, inset). Alternatively, lungs from IKKa cKO mice showed
the lowest overall degree of inflammation (Fig. 2B) at this same
time point. Progressing through days 6 (data not shown) and 9
(Fig. 2D–F and S2), all three strains of mice showed some degree
of thickening in the alveolar walls and septae. Luminal alveolar
exudate and dilated capillaries were sometimes observed, indicating possible onset of a mild interstitial pneumonia. We noted,
on occasion, a minor degree of activation in cells of the mesothelial
lining, a symptom of visceral pleuritis. However, only small areas
were affected and this did not occur with any regularity.
Interestingly, lungs from IKKb cKO infected mice developed
multiple areas of organized lymphocytic aggregates (Fig. 2F), while
this was a rare occurrence in IKKf/f or IKKa cKO mice. These
aggregates resemble inducible bronchial-associated lymphoid

Statistical Analysis
Data were analyzed by one-way ANOVA with Tukey’s multiple
comparison post-test using GraphPad Prism 6 software (GraphPad
Software, Inc., La Jolla, CA).

Results
Reduced Survival of Myeloid IKKb-deficient Mice
Following Lethal Intradermal Ft. LVS Challenge
The IKKs are important signaling factors involved in orchestrating host immune responses to a wide variety of pathogens, yet
the requirements for IKK signaling in myeloid cells during Ft.
LVS infection are unknown. To address this, we employed Cre/
Lox mediated recombination in which IKKa or IKKb are
conditionally deleted from the myeloid compartment of adult mice
[47,49,52].
The severity of Francisella infection varies by bacterial strain,
host genetic background, dose and route of administration
[13,23,53]. In order to establish the correct dosage for our model
system, we began with a pilot experiment in which we intradermally (i.d.) injected IKKf/f mice at various doses of Ft. LVS
in order to establish the median lethal dose (LD50). After retroplate
assay correction, the LD50 was determined to be 108 CFU of Ft.
LVS (Fig. S1 A–C).
We first investigated if either IKKa or IKKb in myeloid cells
were required for host survival to Ft. LVS infection. We injected
IKKf/f, IKKa cKO and IKKb cKO mice with the LD50 dose of
108 CFU Ft. LVS and scored animals for their relative survival
rates. All IKKb cKO mice succumbed to infection by day 10 with
a comparative Log-rank test P value of 0.0014 (Fig. 1); there were
no significant differences in the survival rates among IKKf/f and
IKKa cKO mice.
PLOS ONE | www.plosone.org
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development of granuloma foci, which act as a microenvironment
that serves to contain infection and clear debris from infected and
dying cells [19,23,51,56]. Histological examination of the spleens
from uninfected mice appeared normal and showed clearly
demarcated red and white pulp. Follicles, germinal centers and
the surrounding cuff of the marginal zone were well represented
(data not shown). At two days post infection, the red pulp was
marginally expanded, but other structures were qualitatively
normal in all three strains. A few small granuloma-like lesions
began to appear within the red pulp of most animals (Figs. 3A–C
and Fig. S3). More severe histopathological changes to splenic
architecture progressed through days 6 and 9 post-infection (data

tissue (iBALT), which can be induced in humans and mice upon
exposure to infection and inflammation and are considered
tertiary sites of B and T cell priming reactions [54]. Immunohistochemical analysis to detect Ft. LVS antigen (Fig. S2) showed
a limited infection within the lung parenchyma. The overall
conclusion about lung reactions in all three strains of mice was that
they were relatively mild. These findings are consistent with
previous reports for intradermal infection, not only with Ft. LVS
[55], but also with the more virulent strain Francisella tularensis
Schu4 [23].
The spleen and liver undergo pronounced inflammatory
reactions upon Ft. LVS infection and are characterized by the

Figure 2. Dissemination of Ft. LVS leads to lymphocytic aggregate development in IKKb cKO mouse lung. H & E stained lung tissue was
examined for histological changes at days 2 and 9 (A–F) after i.d. infection with 106 CFU of Ft. LVS. (A) IKKf/f and (B) IKKa cKO mice show evolution
and (D, E) resolution of inflammation, while (C and F) IKKb cKO mice exhibit a delay in resolution concordant with the appearance of (F, inset)
lymphocytic aggregates. Figure insets are taken from regions marked by rectangles. Yellow arrows indicate neutrophils, blue arrows indicate
lymphocytic infiltrate, yellow arrowheads indicate lymphocytic aggregates. Scale bar = 500 mm, 206 magnification, inset scale bar = 50 mm, 4006
magnification). Representative sections are shown from at least three independent experiments.
doi:10.1371/journal.pone.0054124.g002

PLOS ONE | www.plosone.org
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to flow cytometry. Interestingly, IKKb cKO infected mice
showed only modest increases in the number of Ft. LVS positive
macrophages throughout the course of infection (Fig. 5B). To
account for a possible loss of cells due to infection, we analyzed
macrophage and neutrophil cell populations from each strain.
We isolated hepatic NPCs from sublethally Ft. LVS infected
livers and performed a flow cytometry analysis time course to
evaluate the populations of F4/80+ CD11b+ expressing macrophages and Ly6B.2+ expressing neutrophils. Prior to infection
(day 0), all three strains of mice yielded comparable numbers of
macrophages and neutrophils (Fig. 6A & B, respectively). Modest
increases were observed in the macrophage population but
persisted throughout the 8-day time course (Fig. 6A). As early as
two days post infection, increases in neutrophils were evident in
IKKb cKO mice and by day 8, neutrophils were elevated in
both mutant strains, relative to the parental strain (Fig. 6B).
Taken together, these data suggest that the increased liver
burden in IKKb cKO mice or granuloma maintenance were due
to defects in myeloid function related to control of bacterial
growth and spread of infection rather than overt initial increases
in macrophage infection (Fig. 5B) or loss of cells from the
myeloid compartment (Fig. 6A–B).

not shown and Fig. 3D–F, respectively). The white pulp showed
evidence of expansion and macrophage and lymphocytic infiltrates
were seen in the red pulp. The number of granulomas marginally
increased in IKKf/f and IKKa cKO mice. However, in IKKb
cKO infected mice, the red pulp was often completely effaced with
coalescing granulomas making accurate quantification difficult.
Neutrophils were sometimes present within these granulomas
(Fig. 3F, inset). Splenomegaly was apparent in all strains (Fig. 3G).
Comparisons of spleen/total mouse weight ratios (spleen index)
showed a ,3 fold change by day six. The spleen index modestly
increased to 3.5–4 fold by day nine. No significant differences in
spleen indices between strains were observed. Immunohistochemical analysis of Ft. antigen in spleen at 2 days post infection showed
numerous bacterial foci (Fig. S3 A–C) in all three strains of mice.
Bacteria were localized predominantly in the red pulp, but were
occasionally observed in the white pulp as well (Fig. S3 A). By day
9, there was a marked decrease in the number of bacterial foci,
indicating resolution of infection.
Granuloma formation in liver was evident at two days postinfection in all three strains (Fig. 4A–C). At day 2, granuloma
counts in IKKb cKO mice were at least two fold greater in
number than those of IKKf/f or IKKa cKO mice (Fig. 4G,
P,0.0001). By day 9, granuloma formation continued to increase
in IKKb cKO at a rate far greater than either IKKf/f or IKKa
cKO mice. Additionally, the granuloma-like structures that
developed in IKKb cKO infected mice were often extremely
small and decondensed, resulting in livers replete with inflammatory cells (Fig. 4F). Some granulomas in IKKa cKO mice
developed into very large, macroscopically discernable structures
that contained a central core filled with necrotic and cellular debris
(Fig. 4E; note that panel 4E is a lower magnification than 4D and
4F), and although large, these structures were well contained by
a cuff of mononuclear cells, epitheloid histiocytes and occasional
lymphocytes. Although both spleen and liver showed increased
numbers of granuloma foci in IKKb cKO mice, the liver also
showed clear discernable defects in granuloma maintenance in
both mutant strains of mice. Since the liver reacts with a strong
pro-inflammatory response to Ft. LVS intradermal infection [24]
and contains a rich source of macrophages, we focused the
remainder of our experiments on the liver to further investigate the
anti-inflammatory effects of myeloid IKKb during the course of
tularemia.

Myeloid Function in the Granuloma
To further examine myeloid function in liver granulomas, we
performed immunohistochemical assays to detect the spatial
localization of LVS antigen, production of the inflammatory
mediator iNOS (inducible nitric oxide synthase) and induction of
caspase-3 (CC-3) activation. Figure 7 shows representative
granulomas from each of the three strains of mice. LVS antigen
was largely restricted to the granuloma (Fig. 7. A–F), however,
a small number of Ft. antigen positive cells (8-11cells/2006 field)
were sometimes found within the parenchyma. Ft. antigen positive
cells were almost two-fold higher in IKKb cKO mice, but this
correlated with higher bacterial burdens.
Lindgren et al [58] reported that intradermal inoculation of Ft.
LVS in iNOS (inducible Nitric Oxide Synthase) deficient mice
results in decreased host survival, increased bacterial colonization
and increased liver damage concurrent with the appearance of
numerous small granuloma-like foci in the liver. Moreover, iNOS,
in addition to induction by IFN-c, is also a secondary response
target gene activated through TLR signal transduction [59,60].
We next asked if iNOS was similarly expressed in liver granulomas
of IKK deficient mice. At two days post infection, we observed
iNOS positivity in 54%, 40% and 54% in hepatic granulomas
from IKKf/f, IKKa cKO and IKKb cKO mice, respectively (Fig. 7
B, H, N). By nine days post-infection (Fig. 7 E, K, Q), only modest
increases in the number of iNOS-postive granulomas (,10%) in
IKKf/f and IKKb cKO infected mice were noted. In comparison,
the number of IKKa cKO iNOS positive granulomas remained
essentially unchanged at 42%.
Rapid induction of apoptosis in bacterially infected cells is an
immune defense mechanism that helps to limit the spread of
infection. We analyzed induction of apoptosis in hepatic granulomas using the apoptotic marker, cleaved caspase-3 (CC-3). CC-3
staining was largely restricted to granulomas. At early time points
in infection, ,35% of all granulomas scored positive CC-3 in all
strains of mice. However, only a few (,1–8) positive cells were
found per granuloma (Fig. 7M–R), and this was consistent
between all strains of mice. By day nine, CC-3 positive granulomas
from IKKf/f mice was reduced to 11.3%, while IKKa and IKKb
cKO mice retained an overall 25 and 22% CC3 positive
granuloma score, respectively.

Myeloid IKKb is Required for Control of Bacterial Growth
in the Ft. LVS Infected Liver
Bacterial colonization is first detectable in Ft. infected livers at
2–3 days post infection [19,24,51,56]. In order to determine if the
observed granuloma defects in the liver were due to increased
bacterial colonization, a retroplate time course study to determine
organ burden was performed on liver homogenates from mice
infected with 106 CFU of Ft. LVS. At day 2 post infection, both
IKKf/f and IKKa cKO mice showed limited colonization of the
liver while, even at this early time point, IKKb cKO mice
presented with increased bacterial loads that persisted through day
14 (Fig. 5A).
Macrophages are considered a primary cellular target of
Francisella infection [22,57] and are also a major component of
Ft. induced granulomas [51]. Since macrophages are one of the
cell types affected by our conditional knockouts, we next
questioned whether the macrophages from these mice were
comparably infected relative to control mice. To address this,
non-parenchymal cells (NPCs) were isolated from the livers of
infected mice, stained with F4/80 and CD11b antibodies
followed by intracellular staining for Ft. LVS and then subjected
PLOS ONE | www.plosone.org
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Figure 3. Exacerbated histopathology in the spleen in IKKb cKO mice. Spleen sections were stained with H & E and evaluated for
histopathological changes at days 2 and 9 post i.d. infection with 106 CFU of Ft. LVS. Granuloma foci developed in the red pulp of the spleen (yellow
arrowheads) in (A) IKKf/f, (B) IKKa cKO and (C) IKKb cKO mice as early as 2 days post-infection. (D–F) These foci increased in number by day 9. Inset in
(F) is representative of a typical granuloma within the red pulp. The yellow arrow points to a neutrophil within the granuloma. (G) All strains of mice
developed splenomegaly during the course of infection as determined by the spleen index (ratio of spleen weight to body weight6100). Scale bar for
panels A–F = 500 mm, 206 magnification, inset scale bar in F = 50 mm, 4006magnification. Representative sections are shown from at least three
independent experiments.
doi:10.1371/journal.pone.0054124.g003
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Figure 4. Loss of either IKK kinase results in defects in hepatic granuloma development. Comparison of early and late granuloma
development after sublethal i.d. infection with 106 CFU of Ft. LVS. Representative H & E stained liver sections are shown for (A) IKKf/f, (B) IKKa cKO and
(C) IKKb cKO infected mice at two days post-infection. Granulomas, indicated by yellow arrows (406 magnification, scale bars = 500 mm), are
magnified in the inset of each panel (4006 magnification, scale bars = 30 mm). Panels (D–F) are representative granulomas at 9 days post-infection
(panels D and F are 2006 magnification, scale bar = 50 mm; Panel E is 1006magnification, scale bar = 100 mm). (G) Granulomas were quantified as
counts per 2006 field and were analyzed by one-way ANOVA and Tukey’s ad hoc post-test. Data are pooled from two independent experiments
(each with n = 4 mice per group) for a total of n = 8 mice per group; ***P,0.0001.
doi:10.1371/journal.pone.0054124.g004

infection [11], we, therefore, questioned whether this also occurs
in the liver in response to Ft. LVS infection. To address this, mice
were injected i.d. with 106 CFU of Ft. LVS and we analyzed the
NPC fraction isolated from the livers of infected mice in a time
course experiment using flow cytometry. To first broadly identify

IKKb Inhibits Classical/M1 Macrophage Activation in the
Liver in Response to Ft. LVS Infection
IKKb deficiency in myeloid cells was previously reported to
induce classical/M1 macrophage polarization in response to GBS
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Figure 5. IKKb controls Ft. LVS growth in the liver. (A) Organ burdens were determined by retroplate assay from liver homogenates of mice
injected i.d. with 106 CFU Ft. LVS at days 2, 6, 9, and 14. Data is presented as CFU of Ft. LVS per gram of liver. Data were pooled from two independent
experiments. The dashed line represents the assay limit of detection, 200 CFU. (n for IKKf/f, IKKa cKO, IKKb cKO on day 2 = 8; day 6 = 7; day 9 = 6; day
14 n = 6) (B) Liver macrophages were analyzed for infection by flow cytometry. Statistical analysis was performed by one-way ANOVA followed by
Tukey’s ad hoc post-test, (n for IKKf/f, IKKa cKO, IKKb cKO on day 0:5/5/5; day 2:4/4/4; day 6:4/4/4; day 8:4/4/3, respectively). Bars represent the mean
6 SD. **P,0.01, ***P,0.0005, ****P,0.0001.
doi:10.1371/journal.pone.0054124.g005

period early in infection, as by day 6 there was a shift toward M2a
activation as indicated by increases in F4/80+ CD206+ staining in
coordination with several other M2a-associated markers (Fig. 9B–
D) including: IL-10, a 2 fold increase P = 0.0019; FIZZ1, a 6 fold
increase P = 0.0085; and Arg-1, a 9 fold increase P = 0.0041).

M1 and M2a macrophage subpopulations, we scored macrophages for their F4/80 expression and either macrosialin (murine
CD68) or the mannose receptor (CD206), (Fig. 8A and 9A,
respectively). Next, we evaluated each subpopulation for expression of the prototypical M1 cytokine, IL-12 (Fig. 8B) or multiple
M2 activation markers, including IL-10, arginase-1 and RELMa/
FIZZ1 (Fig. 9B–D).
We observed a 5-fold increase (P = 0.0040) in the number of M1
macrophages (F4/80+ CD68+ IL-12+) in IKKb cKO mice at 2
days post-infection (Fig. 8B). This data indicates that myeloid
IKKb contributes to the suppression of M1 classical activation in
the liver in response to sublethal Ft. LVS infection. However, this
IKKb-mediated M1 suppression only occurred in a short time

Livers of Ft. LVS Infected IKKb cKO Mice Present
Protracted Activation of CD8+ T cells in the Liver
We next evaluated the collateral effects of IKK myeloid deletion
with respect to the activation of IFN-c by other cell types after
sublethal i.d. Ft. LVS infection. Again, using a flow cytometric
approach on liver NPCs, we scored for IFN-c activation in NK
(NK1.1+ CD32), CD4+ and CD8+ T cell (CD4+ CD3+ and CD8+

Figure 6. Myeloid lineage response in Ft. LVS infected livers. We analyzed (A) macrophage and (B) neutrophil populations in the liver by flow
cytometry during the course of sublethal Ft. LVS infection. Statistical analysis was performed by one-way ANOVA followed by Tukey’s ad hoc posttest. (n for IKKf/f, IKKa cKO, IKKb cKO on day 0:5/5/5; day 2:4/4/4; day 6:4/4/4; day 8:4/4/3, respectively). Results are representative of at least two
independent experiments. Bars represent the mean 6 SD. *P,0.05, **P,0.01, ***P,0.0005, ****P,0.0001.
doi:10.1371/journal.pone.0054124.g006
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Figure 7. Reactivity of Ft. LVS induced granulomas. Mice were challenged i.d. with 106 CFU of Ft. LVS and livers were analyzed by
immunohistochemistry for anti-Ft. LVS antigen, anti-iNOS and anti-cleaved caspase-3 (CC3) at days 2 and 9 post infection. Ft. LVS antigens were
detected within (A–B) IKKf/f, (C–D) IKKa cKO and (E–F) IKKb cKO granulomas at days 2 and 9, respectively. iNOS positivity was determined for (G–H)
IKKf/f, (I–J) IKKa cKO and (K-L) IKKb cKO mice. Activated caspase-3, an early indicator of apoptosis, was detected in (M-N) IKKf/f, (O–P) IKKa cKO and
(Q–R) in IKKb cKO granulomas at days 2 and 9 post infection, respectively. 2006 magnification, scale bar = 50 mm; d.p.i.: days, post-infection, (n = 4).
doi:10.1371/journal.pone.0054124.g007

CD3+, respectively) populations. The NK cell populations from
IKKa and IKKb cKO infected mice were largely similar to IKKf/f
control animals (Fig. 10A). A small increase in NK cells were seen in
IKKa cKO animals on day 8 post-infection, yet we did not observe
corresponding increases in IFN-c+ cells at the same time point
(Fig. 10B). Increases in both CD4+ and CD8+ T cell populations were
observed at later time points in infection in IKKb cKO mice (Fig. 10C
and E). In CD8+ T cells, these increases correspondingly correlated to
greater increases in the number of IFN-c+ cells (Fig. 10E and F).
Interestingly, increases in IFN-c+ CD8+ T cells from IKKb cKO
infected mice were protracted throughout the entire infection time
course (Fig. 10F). This trend was not observed in IKKf/f or IKKa
cKO infected mice. These results suggest that myeloid IKKb may
function in an extrinsic manner to suppress the influx of activated
IFN-c producing cells.

PLOS ONE | www.plosone.org

Discussion
The results of this work shed new light on the contributions of
the IKKs in myeloid cells during Ft. LVS infection and also extend
previous findings on the in vivo roles of the IKKs in myeloid cells in
response to bacterial infections. In spite of the anti-inflammatory
properties demonstrated by others [9,10,11], myeloid IKKs
exhibit notable differences in response to the intracellular
bacterium Ft. LVS. Here, we found that myeloid IKKb has
a protective role in response to lethal challenge. At sub-lethal
doses, histopathology and retroplate culture assays showed that
myeloid IKKb helps regulate the granulomatous response and
control infection.
We also examined the effect loss myeloid IKKb had on
macrophage polarization. Indeed, IKKb inhibits classical M1
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Figure 8. Loss of IKKb induces temporal M1 activation in response to Ft. LVS. Hepatic NPCs were isolated from IKKf/f, IKKa and IKKb cKO
mice infected with 106 CFU of Ft. LVS i.d. and analyzed by flow cytometry for M1 activation. (A) Pro-inflammatory macrophages were identified by
their F4/80 and macrosialin (CD68) expression and then scored for M1 activation by (B) IL-12 expression. Statistical analysis was performed by oneway ANOVA followed by Tukey’s ad hoc post-test. (n for IKKf/f, IKKa cKO, IKKb cKO on day 0:5/5/5; day 2:4/4/4; day 6:4/4/4; day 8:4/4/3). Results are
representative of at least two independent experiments. Bars represent the mean 6 SD. **P,0.01.
doi:10.1371/journal.pone.0054124.g008

macrophage activation. However, this effect was limited to early
time points of infection, in spite of a protracted elevation of IFN-c+
CD8+ T cells during the course of infection. On the contrary, we
observed only limited roles for myeloid IKKa during Ft. LVS
infection. Loss of myeloid IKKa resulted in similar survival rates
compared to control mice and a reduction in bacterial colonization at early time points. The most notable difference in IKKa
cKO mice was in the appearance of large, necrotic, granulomalike foci, which formed in the liver at late stages of infection,
suggesting that IKKa in myeloid cells may be involved in
clearance of dying cells. These foci were cleared after 90 days of
infection (data not shown) by a yet unknown mechanism.

Moreover, increased mortality occurred in myeloid IKKb deficient mice at the LD50 dose of 108 CFU of Ft. LVS, indicating
a protective role for myeloid IKKb during overwhelming sepsis.
IKKb deficiency also resulted in a dose-dependent survival
response, an effect which has been observed, to varying degrees,
for other components involved in NF-kB signaling. For example,
loss of either TLR2 (Toll-like receptor 2) [62] or MyD88 [55]
results in reduced survival as a result of tularemic infection. Yet,
loss of TLR2 affects survival at moderate infection doses
(,46104 CFU) [62], while MyD88 deficient mice are extremely
sensitive and succumb to Ft. LVS at infection doses orders of
magnitude lower (56101 CFU) [55]. The increased sensitivity of
MyD88 loss is due to its requirement in multiple signaling
pathways. Studies show that MyD88 loss affects the NF-kB, c-Jun
and p38 MAPK pathways with delayed kinetics [63], abrogated
IL-1R- and IL-18R -mediated cytokine production [64], as well as
impaired IFN-c and TNF-a production in response to several
pathogens [63,64]. In addition, it is important to note that the
dose-specific sensitivity to Ft. LVS in the TLR2 and MyD88
studies were performed in full knockout models, while the IKKb
model used here was conditionally restricted to the myeloid
compartment. Thus, this is the first study to show a myeloidspecific requirement for host survival in response to Francisella
tularensis.

IKKb but not IKKa in Myeloid Cells Contributes to Host
Survival to a Lethal Dose of Ft. LVS
The survival results we obtained in our study are in contrast to
those reported for myeloid IKK deficient mice responding to
a lethal Gram-positive bacterium GBS (Group B Streptococcus)
challenge [10,11]. In this previous study, mice devoid of myeloid
IKKb were more resistant to a lethal challenge with GBS [11].
Here, we found that intradermal inoculation with Gram-negative
bacterium, Ft. LVS rendered myeloid IKKb deficient mice much
more susceptible to lethal infection. These results correspondingly
correlated to levels of bacterial titers, as there was increased
bacterial clearance in the GBS model [11], while we observed
increased colonization in the Ft. LVS model. In addition, loss of
functional IKKa (ikka AA/AA phosphorylation mutant) in the
myeloid compartment results in increased susceptibility to GBS
infection [10], while here, we found IKKa cKO mice maintain
a comparable susceptibility in response to Ft. LVS infection to
control animals. These contrasting results in survival between the
Francisella and GBS infection models in myeloid IKK deficient
mice suggest that there are differential requirements for downstream TLR effectors, such as the IKKs, during septic challenge.
In fact, similar differences in survival patterns have been reported
for the TLR adapter protein MyD88 (Myeloid-differentiation
factor 88). Mice deficient in MyD88 are protected from GBS
infection at high infection doses, [61], while Ft. LVS infected mice
are extremely susceptible to MyD88 loss at low doses [55].
PLOS ONE | www.plosone.org

Ft. LVS Disseminates to Lung, Liver and Spleen
Dissemination of bacteria led to bacterial colonization in lung,
spleen and liver tissues. Only mild histopathological findings in
lung tissue were found. One unexpected finding was the development of organizing lymphocytic aggregates within the lungs
IKKb cKO mice after infection. These aggregates, also known as
iBALT (inducible bronchus-associated lymphoid tissue), are not
present in normal lung in humans or mice, but can be induced
after exposure to antigen, inflammation or infection (reviewed in
[65,66]). In mice lacking spleen, lymph nodes and Peyer’s patches,
iBALT acts as a site of B and T cell proliferation in response to
influenza infection and is considered protective in nature [54].
iBALT develops under pathologic states, and it is suggested that
this may involve the activation of PRR (pattern recognition
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Figure 9. Switch to M2a polarization in IKKb cKO mice at mid-infection stage. M2a activation occurs in IKKb cKO mice after sublethal i.d.
infection with 106 Ft. LVS as evidenced by expression of (A) CD206 (B) IL-10 (C) FIZZ1/Relma and (D) Arg-1 in a flow cytometry time course
experiment. Statistical analysis was performed by one-way ANOVA followed by Tukey’s ad hoc post-test. (n for IKKf/f, IKKa cKO, IKKb cKO on day 0:5/5/
5; day 2:4/4/4; day 6:4/4/4; day 8:4/4/3). Results are representative of at least two independent experiments. Bars represent the mean 6 SD. **P,0.01.
doi:10.1371/journal.pone.0054124.g009

granulomas, although a limited number of infected cells could
be detected within the parenchyma.
In the liver, iNOS (inducible nitric oxide synthase) is produced
by macrophages and hepatocytes and can be induced by microbial
lipoproteins through TLR activation, IFN-c or TNF-a. iNOS
mediates the metabolic conversion of L-arginine to NO (nitric
oxide) and citrulline. NO is not only a powerful antimicrobial
effector molecule capable of direct killing, it is also involved in
several other aspects of host defense including cytokine production
and apoptosis [70]. iNOS expression within granulomas was
previously reported to be low and infrequent during intradermal
infection [24]. However, we found 40–54% of hepatic granulomas
were positive for iNOS induction by day 2, with only marginal
changes in expression throughout the course of infection. Thus, it
is unlikely that the observed defects in granuloma maintenance
result from aberrant iNOS induction.
Apoptosis is considered an important immune defense mechanism. Rapid elimination of infected cells helps prevent the spread
of infection to other cells and also promotes dendritic cell uptake of
apoptotic bodies, allowing access to antigen which may trigger
both innate and adaptive immune responses. However, many

receptors) such as the TLRs [65]. Although further examination
into the development of iBALT structures in IKKb cKO mouse
lung was beyond the scope of this current investigation, it is of note
that these structures were previously identified in a number of Ft.
LVS vaccine studies. Organized lymphoid structures are induced
upon aerosol or intranasal administration of vaccines using whole
[67], inactivated Ft. LVS [68] or Ft. LVS LPS plus adjuvant [69].
However, unlike these studies, where mice were immunized with
several repeated doses of bacteria, our model consisted of a single
intradermal inoculation. It is possible that the increased bacterial
burden in IKKb cKO mice, induces these structures as a result of
ongoing and repeated exposure to Ft. antigen. Furthermore,
iBALT structures persist in these mice well after bacterial
clearance and are still evident at 90 days post infection (S.S.,
unpublished data).
IKKb cKO mice responded to infection with an increased
frequency in granuloma response in both spleen and liver. IKKa
cKO mice developed some abnormally large granulomas within
liver; however, the spleen granuloma reaction was qualitatively
and quantitatively similar to IKKf/f mice. Analysis of Ft. antigen in
the liver showed the bacteria were mainly localized within
PLOS ONE | www.plosone.org
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Figure 10. Protracted hepatic activation of CD8+ T cells in IKKb cKO Ft. LVS infected mice. Hepatic (A) Natural killer (NK1.1+CD32), (B)
CD4+CD3+ and (C) CD8+CD3+ T-lymphocytes and their (D–F) IFN-c expression, respectively, were analyzed by flow cytometry in Ft. LVS infected mice.
Statistical analysis was performed by one-way ANOVA followed by Tukey’s ad hoc post-test. (n for IKKf/f, IKKa cKO, IKKb cKO on day 0:5/5/5; day 2:4/4/
4; day 6:4/4/4; day 8:4/4/3). All results are representative of at least two independent experiments. Bars represent the mean 6 SD. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0054124.g010

pathogens have evolved mechanisms to escape destruction by
subverting or redirecting these processes (reviewed in [71]). We
found the early apoptosis marker, cleaved caspase-3 (CC-3),

PLOS ONE | www.plosone.org

spatially localized within the granulomas in all three strains of
mice. We found no overt differences between strains in the
percentage of CC-3-positve granulomas at early time points.
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In summary, we show that myeloid IKKb has a protective role
in controlling bacterial growth that leads to overwhelming sepsis
during tularemic infection. Furthermore, macrophage polarization
vs. bacterial control and survival appear to be functionally distinct
processes regulated by myeloid IKKb. In addition, we also found,
in our model system, that IKKb-dependent macrophage polarization is a short-term phenomenon. Contrary to this, we found no
evidence of anti-inflammatory properties for myeloid IKKa in vivo.

Furthermore, only a few cells per granuloma stained positive for
this marker, but this was consistent with other models of
intradermal Ft. LVS infection [51]. Lawrence et al suggests that
increased bactericidal control in a GBS model of pneumonia
observed in ikka AA/AA macrophages is due, in part, to increased
activation of anti-apoptotic genes combined with sustained
activation of inflammatory genes such as iNOS [10]. In the Ft.
LVS model, these effects on apoptosis and iNOS production were
not evident, suggesting that the molecular mechanisms between
these two infection models are different. Furthermore, GBSinfected ikka AA/AA mice, despite increased bacterial clearance at
early time points, eventually succumb to infection, whereas
survival in IKKa cKO mice infected at the LD50 dose of
108 CFU of Ft. LVS are similar to wild type mice.

Supporting Information
Figure S1 LD50 and sublethal Ft. LVS dose determina-

tions. (A) IKKf/f control mice (n = 5 mice/group) were injected
with Ft. LVS i.d. at the indicated doses and analyzed for survival
by Kaplan-Meier method in order to determine the median lethal
dose. The inoculation dose was confirmed by retroplate assay and
the LD50 was estimated at 108 CFU. In panels (B) and (C), IKKf/
f
, IKKa cKO and IKKb cKO mice were injected with Ft. LVS i.d
at two different sublethal doses: (B) 107 CFU and (C) 106 CFU,
and analyzed for long-term survival (n = 5–6 mice/group).
(TIF)

IKKb Deficiency in Myeloid Cells Causes Time Dependent,
Differential Effects on M1 vs M2 Macrophage Polarization
in Response to Sublethal Ft. LVS Infection
Despite differences in survival, the observation that myeloid
IKKb deficiency induces M1/classical activation in the livers of Ft.
LVS infected mice is in accord with the GBS infection model [11].
Because our model system allows us to monitor macrophage
polarization over days, not hours (as is the case in GBS model), we
also discovered that IKKb cKO mice undergo a second wave of
polarization toward M2/alternatively activated macrophages at
the mid-infection stage. Although we cannot rule out that this
second wave of polarization stems from secondary or bystander
effects induced by the local environment, it is of note that the antiinflammatory IKKb-dependent blockade of M1 classical macrophage activation is transient in nature and thus an important
consideration for design of therapeutic targeting.

Figure S2 Minimal lung involvement after intradermal
Ft. LVS challenge. Lung sections, taken from mice i.d.
challenged with a sublethal dose of 106 CFU Ft. LVS, were
analyzed by immunohistochemistry for Ft. LVS antigen. (A) and
(D) IKKf/f, (B) and (E) IKKa cKO, and (C) and (F) IKKb cKO
are representative lung sections showing low Ft. LVS colonization
at days 2 and 9 post infection, respectively. Magnification = 1006,
scale bar = 100 mm.
(TIF)
Figure S3 Ft. LVS dissemination in spleen. Spleen sections
from mice i.d. challenged with a sublethal dose of 106 CFU Ft.
LVS, were analyzed by immunohistochemistry for Ft. LVS
antigen. (A) and (D) IKKf/f, (B) and (E) IKKa cKO, and (C)
and (F) IKKb cKO are representative sections of spleens at days 2
and 9 post infection, respectively. Magnification = 1006, scale
bar = 100 mm.
(TIF)

IKKb Loss in Myeloid Cells Results in Collateral Effects on
IFN-c Producing Cells
The compounding effects of increased bacterial titers and M1/
M2 activation defects in IKKb cKO mice also correlated with
increases in several types of IFN-c expressing cells. Furthermore,
protracted elevations in IFN-c expressing CD8+ T cells were
protracted throughout the course of infection. Elevations of these
cells persisted, despite the mid-infection shift in M2 macrophage
polarization. It has long been considered that early tularemic
infection is controlled by T cell-independent events, as T cell
depleted mice (depleted of both CD4+ and CD8+ T cells) survive
initial infection, but fail to clear bacteria and succumb to infection
several weeks after inoculation [72,73,74]. Interestingly, mice
selectively depleted for only CD4+ T cells or CD8+ T cells are able
to resolve and survive infection [75]. This implies that these T cell
subsets have roles in clearance and resolution of infection that
largely overlap. Although the exact mechanism(s) by which
myeloid IKKb deficiency results in a collateral elevation of
reactive CD8+ T cells remains to be determined, our data suggest
that when myeloid NF-kB is impaired due to loss of IKKb, CD8+
T cells overtly respond as an immunologic compensatory
mechanism. Therefore, it seems that CD8+ T cells are poised to
react during the T-cell independent phase of Ft. infection.
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